We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+13.16%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$14.9B
AUM Growth
+$995M
Cap. Flow
-$291M
Cap. Flow %
-1.95%
Top 10 Hldgs %
26.38%
Holding
2,856
New
31
Increased
336
Reduced
1,500
Closed
71

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$28.4M
2
MSFT icon
Microsoft
MSFT
+$25.6M
3
NVDA icon
NVIDIA
NVDA
+$15.2M
4
AMZN icon
Amazon
AMZN
+$11.2M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 27.53%
2 Financials 12.17%
3 Healthcare 11.68%
4 Consumer Discretionary 10.99%
5 Industrials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCB icon
1026
ArcBest
ARCB
$3.28B
$1.72M 0.01%
12,085
-518
-4% -$67.8K
SWTX
1027
DELISTED
SpringWorks Therapeutics
SWTX
$1.72M 0.01%
34,920
-452
-1% -$20.9K
IVZ icon
1028
Invesco
IVZ
$14.3B
$1.72M 0.01%
103,556
-3,887
-4% -$62.7K
RL icon
1029
Ralph Lauren
RL
$23.1B
$1.72M 0.01%
9,146
-505
-5% -$83.6K
CRI icon
1030
Carter's
CRI
$1.44B
$1.71M 0.01%
20,213
-533
-3% -$42.3K
CVCO icon
1031
Cavco Industries
CVCO
$4.67B
$1.71M 0.01%
4,287
-298
-6% -$106K
FOLD
1032
DELISTED
Amicus Therapeutics
FOLD
$1.71M 0.01%
145,110
-3,556
-2% -$45.5K
ENOV icon
1033
Enovis
ENOV
$1.48B
$1.71M 0.01%
27,346
-719
-3% -$43K
CNXC icon
1034
Concentrix
CNXC
$1.52B
$1.71M 0.01%
25,769
-828
-3% -$67.2K
CMA
1035
DELISTED
Comerica
CMA
$1.7M 0.01%
30,874
-1,129
-4% -$58.9K
RUSHA icon
1036
Rush Enterprises Class A
RUSHA
$9.62B
$1.7M 0.01%
31,688
-890
-3% -$42.1K
BIO icon
1037
Bio-Rad Laboratories Class A
BIO
$9.66B
$1.69M 0.01%
4,893
-182
-4% -$59.8K
SAM icon
1038
Boston Beer
SAM
$1.9B
$1.68M 0.01%
5,530
-135
-2% -$45K
REZI icon
1039
Resideo Technologies
REZI
$3.1B
$1.68M 0.01%
75,068
-1,812
-2% -$35.8K
WHD icon
1040
Cactus
WHD
$5.78B
$1.67M 0.01%
33,247
-849
-2% -$37.6K
STRL icon
1041
Sterling Infrastructure
STRL
$16.9B
$1.66M 0.01%
15,072
-378
-2% -$34.3K
COIN icon
1042
Coinbase
COIN
$40.6B
$1.66M 0.01%
6,264
+1,091
+21% +$196K
NSA
1043
DELISTED
National Storage Affiliates Trust
NSA
$1.66M 0.01%
42,392
-1,240
-3% -$46.6K
WD icon
1044
Walker & Dunlop
WD
$1.47B
$1.66M 0.01%
16,389
-410
-2% -$39.4K
ABCB icon
1045
Ameris Bancorp
ABCB
$6B
$1.65M 0.01%
34,159
-797
-2% -$38.6K
IOSP icon
1046
Innospec
IOSP
$2.31B
$1.65M 0.01%
12,816
-345
-3% -$41.9K
AMED
1047
DELISTED
Amedisys
AMED
$1.65M 0.01%
17,915
-474
-3% -$44.4K
XRAY icon
1048
Dentsply Sirona
XRAY
$2.31B
$1.65M 0.01%
49,591
-1,825
-4% -$62.4K
CXT icon
1049
Crane NXT
CXT
$2.96B
$1.64M 0.01%
26,519
-698
-3% -$40.9K
DIOD icon
1050
Diodes
DIOD
$4.48B
$1.64M 0.01%
23,227
-588
-2% -$40.8K

Similar funds

MetLife Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, MetLife Investment Management held 2,856 positions worth $14.9B, up 7.2% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.6%. MetLife Investment Management opened 31 new positions and exited 71, leaving the 2,856-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q1 2024 buy was Flutter Entertainment: 9,898 shares worth $1.98M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $128M increase.
  • MetLife Investment Management's biggest Q1 2024 reduction was Apple, cutting an estimated $28.4M.
  • MetLife Investment Management fully exited Immunogen Inc in Q1 2024, selling an estimated $3.72M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $14.9B portfolio in Q1 2024.
  • MetLife Investment Management opened 31 new positions and closed 71 in Q1 2024.
  • MetLife Investment Management's portfolio value rose 7.2% quarter-over-quarter to $14.9B.

Based on MetLife Investment Management's 13F filing for Q1 2024, filed 14 May 2024.